Update on the diagnosis and treatment of pulmonary embolism

Authors

  • Vedat Eljezi Author

DOI:

https://doi.org/10.59928/98676t96

Abstract

Background: The pulmonary embolism is a frequent cardiovascular syndrome associated with a high mortality and important medical costs. Objective and Method: The purpose of this short review is to update clinicians’ knowledge on the diagnosis and management of patients with pulmonary embolism. Results: The predisposing factors for pulmonary embolism can be classified into three groups according to their importance. The main cause of death is the acute right ventricular failure due to acute increase in pressure. The symptomatology of pulmonary embolism is highly varied, ranging from asymptomatic patients to those presenting with major hemodynamic instability and shock. The diagnosis of pulmonary embolism is based on three essential factors: clinical elements summarized by various validated scores, D-Dimer assays and imaging methods. The emergency nature of treatment depends on the assessment of hemodynamic stability. Severe forms presenting with hemodynamic instability or cardiac arrest require immediate treatment with thrombolysis or surgical/percutaneous embolectomy if thrombolysis is contraindicated. Other supportive measures include empirical anticoagulation based on clinical suspicion, and respiratory/cardiovascular support. Conclusion: Pulmonary embolism remains a frequent and serious disease. This brief summary provides an update on the management of patients suffering from pul monary embolism. Its aim is to help clinicians to accurately diagnose and manage this group of patients. Update on the diagnosis and treatment of pulmonary embolism Venous thromboembolism, clinically presented as deep vein thrombosis (DVT or pulmonary embolism (PE), is the third most frequent acute cardiovascular syndrome, after myocardial infarction and cerebrovascular accident. The annual incidence of pulmonary embolism ranges from 40-120 per 100,000 inhabitants with a mortality of 14% (in-hospital) and 20% in 90 days. The incidence of deep venous thrombosis (DVT) is 53-162 per 100,000 inhabitants and is eight times higher in individuals aged ⩾ 80 years compared to the fifth decade of life. The cost of these diseases in the EU amounts to €8.5 billion. Pulmonary embolism causes 300,000 deaths annually in the US. The mortality rate of cases with acute pulmonary embolism may be decreasing, while diagnosis is increasing.

Downloads

Published

15-12-2023